Preoperative Assessment and Individualized Operation Optimization of Acute Ruptured Cerebral Aneurysms (PAOCA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02977520|
Recruitment Status : Unknown
Verified November 2016 by Beijing Luhe Hospital.
Recruitment status was: Recruiting
First Posted : November 30, 2016
Last Update Posted : November 30, 2016
|Condition or disease||Intervention/treatment||Phase|
|Printing, Three-Dimensional, Simulation Training||Procedure: Printing, Three-Dimensional||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Preoperative Assessment and Individualized Operation Optimization of Acute Ruptured Cerebral Aneurysms|
|Study Start Date :||November 2016|
|Estimated Primary Completion Date :||May 2017|
Experimental: Interventional group
Obtain the CTA data of cerebral aneurysms and built the 3D printing models. Combined with the 3D model, the neurosurgeon can complete the discussion of preoperative prediction of aneurysms and recognize the adjacent bone, blood vessels, aneurysm directions and so on. In addition, the model can also be used to the young doctor's training, and the patient and their families can be convenient and intuitive understanding of the disease, so as to form a good communication between doctors and patients.
Procedure: Printing, Three-Dimensional
To establish 3D model of cerebral aneurysms and have preoperative evaluation.
No Intervention: general group
Obtain the CTA data of cerebral aneurysms, the neurosurgeon complete the discussion of preoperative prediction of aneurysms.
- time of operation [ Time Frame: 1 to 3 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02977520
|Contact: QING HUANG, M.D.||86-10-69543901 ext email@example.com|
|Contact: YANLONG HU, M.D.||86-10-69543901 ext firstname.lastname@example.org|
|Beijing Luhe hospital||Recruiting|
|Beijing, Beijing, China, 101149|
|Contact: QING HUANG, M.D. 86-10-69543901 ext 2053 email@example.com|
|Principal Investigator: QING HUANG, M.D.|